GMI Reporter, GreenMedInfo

A US Food & Drug Administration advisory committee meeting titled “Vaccines and Related Biological Products,” presented online on October 22, 2020, included a 27 slide powerpoint presentation by Steve Anderson, PhD, MPP Director, Office of Biostatistics & Epidemiology, Center for Biologics Evaluation and Research (CBER).

Slide 16 of his presentation included a “DRAFT Working list of possible adverse event outcomes” associated with the imminent rollout of COVID-19 vaccines subject to FDA safety surveillance, showing that death, as well as 21 other conditions (most of which are possibly life-threatening), are listed as possible adverse outcomes of the COVID-19 vaccines.